- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
PSA screening in New Zealand: Total population results and general practitioners' current attitudes and practices - Abstract
November 19, 2013
Development of a peptide-based vaccine targeting TMPRSS2:ERG fusion-positive prostate cancer - Abstract
November 19, 2013
A urologic oncology roundtable discussion: Issues to consider in choosing treatment for metastatic castration-resistant prostate cancer - Abstract
November 19, 2013
Long-term follow-up of International Prostate Symptom Score (IPSS) in men following prostate brachytherapy - Abstract
November 18, 2013
Permanent prostate brachytherapy extracapsular radiation dose distributions: Analysis of a multi-institutional database - Abstract
November 18, 2013
Regional variation in quality of prostate cancer care - Abstract
November 18, 2013
Psychological impact of prostate biopsy: Physical symptoms, anxiety, and depression - Abstract
November 18, 2013
Robust plan optimization for electromagnetic transponder guided hypo-fractionated prostate treatment using volumetric modulated arc therapy - Abstract
November 18, 2013
Cancer-associated bone disease - Abstract
November 18, 2013
Algeta ASA: Xofigo® (radium Ra 223 dichloride) granted marketing authorization in the European Union
November 15, 2013
Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy - Abstract
November 15, 2013
Post-radical prostatectomy predictive factors for biochemical recurrence - Abstract
November 15, 2013
Diagnosis and multimodal therapy for extragastrointestinal stromal tumor of the prostate: A case report - Abstract
November 15, 2013